Evidence map›Paper›PMID 37269080›Full record

ArticleCNS neuroscience & therapeutics2023

USP14 inhibition promotes recovery by protecting BBB integrity and attenuating neuroinflammation in MCAO mice.

Wenzhong Hou, Jianping Yao, Junjie Liu, Xiaohong Lin, JueXian Wei, Xiaofan Yin, Hongbiao Huang, Xiaohui Chen, Guo-Yuan Yang, Xiaosong He

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Wenzhong HouDepartment of Cerebrovascular Disease, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qianyuan, China.
Jianping YaoDepartment of Anatomy, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, China.
Junjie LiuDepartment of Anatomy, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, China.
Xiaohong LinDepartment of Anatomy, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, China.
JueXian WeiDepartment of Emergency, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Xiaofan YinDepartment of Emergency, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Hongbiao HuangDepartment of Pathophysiology, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Xiaohui ChenDepartment of Emergency, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Guo-Yuan YangNeuroscience and Neuroengineering Center, Shanghai Jiao Tong University School of Biomedical Engineering, Shanghai, China.
Xiaosong HeDepartment of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.ORCID 0000-0002-3718-6908
Guangzhou Medical University · CNSecond Affiliated Hospital of Guangzhou Medical University · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimBlood-brain barrier (BBB) dysfunction is one of the hallmarks of ischemic stroke. USP14 has been reported to play a detrimental role in ischemic brain injury. However, the role of USP14 in BBB dysfunction after ischemic stroke is unclear.

methodsIn this study, we tested the role of USP14 in disrupting BBB integrity after ischemic stroke. The USP14-specific inhibitor IU1 was injected into middle cerebral artery occlusion (MCAO) mice once a day. The Evans blue (EB) assay and IgG staining were used to assess BBB leakage 3 days after MCAO. FITC-detran test was slected to examine the BBB leakage in vitro. Behavior tests were conducted to evaluate recovery from ischemic stroke.

resultsMiddle cerebral artery occlusion increased endothelial cell USP14 expression in the brain. Furthermore, the EB assay and IgG staining showed that USP14 inhibition through IU1 injection protected against BBB leakage after MCAO. Analysis of protein expression revealed a reduction in the inflammatory response and chemokine release after IU1 treatment. In addition, IU1 treatment was found to rescue neuronal loss resulting from ischemic stroke. Behavior tests showed a positive effect of IU1 in attenuating brain injury and improving motor function recovery. In vitro study showed that IU1 treatment could alleviate endothelial cell leakage induced by OGD in cultured bend.3 cells through modulating ZO-1 expression.

conclusionsOur results demonstrate a role for USP14 in disrupting the integrity of the BBB and promoting neuroinflammation after MCAO.

Indexed as

Blood-Brain BarrierBrain InjuriesBrain IschemiaIschemic StrokeAnimalsEndothelial CellsEvans BlueImmunoglobulin GInfarction, Middle Cerebral ArteryMiceNeuroinflammatory DiseasesStrokeEvans BlueImmunoglobulin Gbehavior recoveryblood-brain barrierischemic strokeneuroinflammationUSP14

Identifiers

PMID37269080
PMCPMC10580339
OpenAlexW4379197330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.